Skip to content

    Diabetes Health Center

    Font Size

    Insulin-Metformin Combo Tied to Poorer Survival

    Other experts dispute the study's conclusions


    Focusing on about 2,400 patients who added insulin to metformin and just over 12,000 patients who added a sulfonylurea, Roumie's group found that during an average of 14 months of follow-up, the rate of heart attacks and strokes was similar in both groups. However, the rate of death from any cause was higher among those patients taking insulin, the investigators reported.

    Other experts dispute the study's conclusions.

    Dr. Robert Ratner, chief scientific and medical officer at the American Diabetes Association, said, "I disagree with metformin and insulin being a bad combination."

    Ratner said that there are other factors that could explain the results of this study. Those placed on insulin had higher blood sugar levels and had other serious medical conditions, he said.

    "These were not equivalent populations. If you're sicker, then it's not surprising you're going to have worse outcomes," Ratner said.

    Ratner noted that a randomized trial that compared these same drug combinations, called the ORIGIN trial (Outcome Reduction With Initial Glargine Intervention), which followed some 12,000 patients over seven years, came to a different conclusion.

    "What they found in ORIGIN was there was no difference in heart attacks or strokes between the two groups, there was no difference in cancer, and there was no difference in all-cause deaths," he explained. "So the better study showed no difference."

    Ratner said, based on this current study, there is no reason to change treatment.

    Dr. Joel Zonszein, director of the Clinical Diabetes Center at Montefiore Medical Center in New York City, agreed. "You cannot make any conclusions from this study," he said.

    "We are using much newer medications," Zonszein said. "In the VA, they don't use those new medications. They use medications from the last century. The VA continues to use inexpensive therapy that is not very effective."

    Zonszein said that new drugs such as Victoza or Januvia are very expensive and often are not covered by insurance, or if they are, they have very high co-pays.

    Ratner added, "We really don't know what the best drug is to add after metformin." The American Diabetes Association recommends an individualized patient approach that takes into account the patient's condition as well as the cost of treatment, he said.

    A new trial is getting underway that might better pinpoint the most effective and safe treatment, Ratner said. The new study will compare adding insulin or a sulfonylurea or newer drugs like Victoza or Januvia to metformin. "Hopefully, we will have a much better answer in the next several years," Ratner added.

    1 | 2

    Today on WebMD

    Diabetic tools
    Symptoms, diagnosis, treatment, and more.
    woman flexing muscles
    10 strength training exercises.
    Blood sugar test
    12 practical tips.
    Tom Hanks
    Stars living with type 1 or type 2.
    kenneth fujioka, md
    Can Vinegar Treat Diabetes
    Middle aged person
    jennie brand miller

    Prediabetes How to Prevent Type 2 Diabetes
    type 2 diabetes
    food fitness planner